301 related articles for article (PubMed ID: 25673120)
1. Value of Laryngeal Electromyography in Spasmodic Dysphonia Diagnosis and Therapy.
Yang Q; Xu W; Li Y; Cheng L
Ann Otol Rhinol Laryngol; 2015 Jul; 124(7):579-83. PubMed ID: 25673120
[TBL] [Abstract][Full Text] [Related]
2. Quantitative laryngeal electromyography parameters may correlate with improved outcomes following botulinum toxin injection for spasmodic dysphonia.
Dwyer CD; Leclerc AA; Nandedkar SD; Young VN; Rosen CA
Muscle Nerve; 2021 Apr; 63(4):525-530. PubMed ID: 33382480
[TBL] [Abstract][Full Text] [Related]
3. Effects of Voice Therapy on Laryngeal Motor Units During Phonation in Chronic Superior Laryngeal Nerve Paresis Dysphonia.
Kaneko M; Hitomi T; Takekawa T; Tsuji T; Kishimoto Y; Hirano S
J Voice; 2018 Nov; 32(6):729-733. PubMed ID: 28967588
[TBL] [Abstract][Full Text] [Related]
4. Vocal Parameters and Self-Perception in Individuals With Adductor Spasmodic Dysphonia.
Rojas GVE; Ricz H; Tumas V; Rodrigues GR; Toscano P; Aguiar-Ricz L
J Voice; 2017 May; 31(3):391.e7-391.e18. PubMed ID: 27866691
[TBL] [Abstract][Full Text] [Related]
5. Value of laryngeal electromyography in diagnosis of vocal fold immobility.
Xu W; Han D; Hou L; Zhang L; Zhao G
Ann Otol Rhinol Laryngol; 2007 Aug; 116(8):576-81. PubMed ID: 17847724
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
8. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor.
Orbelo DM; Duffy JR; Hughes Borst BJ; Ekbom D; Maragos NE
J Voice; 2014 Jan; 28(1):123-7. PubMed ID: 24080335
[TBL] [Abstract][Full Text] [Related]
9. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
Meyer TK; Hu A; Hillel AD
Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
[TBL] [Abstract][Full Text] [Related]
10. Spasmodic dysphonia: botulinum toxin injection after recurrent nerve surgery.
Ludlow CL; Naunton RF; Fujita M; Sedory SE
Otolaryngol Head Neck Surg; 1990 Feb; 102(2):122-31. PubMed ID: 2113236
[TBL] [Abstract][Full Text] [Related]
11. Laryngeal reinnervation featuring refined nerve-muscle pedicle implantation evaluated via electromyography and use of coronal images.
Sanuki T; Yumoto E; Nishimoto K; Kodama N; Kodama H; Minoda R
Otolaryngol Head Neck Surg; 2015 Apr; 152(4):697-705. PubMed ID: 25672837
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing botulinum toxin dose instability in spasmodic dysphonia patients.
Rosow DE; Pechman A; Saint-Victor S; Lo K; Lundy DS; Casiano RR
J Voice; 2015 May; 29(3):352-5. PubMed ID: 25242042
[TBL] [Abstract][Full Text] [Related]
13. Spasmodic dysphonia follow-up with videolaryngoscopy and voice spectrography during treatment with botulinum toxin.
Esposito M; Dubbioso R; Apisa P; Allocca R; Santoro L; Cesari U
Neurol Sci; 2015 Sep; 36(9):1679-82. PubMed ID: 25966878
[TBL] [Abstract][Full Text] [Related]
14. The cricothyroid muscle does not influence vocal fold position in laryngeal paralysis.
Koufman JA; Walker FO; Joharji GM
Laryngoscope; 1995 Apr; 105(4 Pt 1):368-72. PubMed ID: 7715379
[TBL] [Abstract][Full Text] [Related]
15. Histology of nerves and muscles in adductor spasmodic dysphonia.
Chhetri DK; Blumin JH; Vinters HV; Berke GS
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):334-41. PubMed ID: 12731628
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of botulinum toxin injections in spasmodic dysphonia.
Davidson BJ; Ludlow CL
Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):33-42. PubMed ID: 8546422
[TBL] [Abstract][Full Text] [Related]
18. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor.
Kendall KA; Leonard RJ
J Voice; 2011 Jan; 25(1):114-9. PubMed ID: 20137891
[TBL] [Abstract][Full Text] [Related]
19. Laryngeal myofascial pain syndrome as a new diagnostic entity of dysphonia.
Jung SY; Park HS; Bae H; Yoo JH; Park HJ; Park KD; Kim HS; Chung SM
Auris Nasus Larynx; 2017 Apr; 44(2):182-187. PubMed ID: 27262220
[TBL] [Abstract][Full Text] [Related]
20. Refractory Dysphonia Due to Isolated Cricothyroid Muscle Dystonia.
Kraft S; Childes J; Hillel A; Schindler J
J Voice; 2016 Jul; 30(4):501-5. PubMed ID: 26239970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]